ジーエヌアイグループの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/01/21 | 3,640 | 3,700 | 3,455 | 3,470 | -125 | -3.5% | 199,100 |
2019/01/18 | 3,575 | 3,640 | 3,530 | 3,595 | +80 | +2.3% | 164,900 |
2019/01/17 | 3,440 | 3,535 | 3,435 | 3,515 | +120 | +3.5% | 188,000 |
2019/01/16 | 3,435 | 3,490 | 3,370 | 3,395 | -15 | -0.4% | 152,900 |
2019/01/15 | 3,235 | 3,470 | 3,225 | 3,410 | +185 | +5.7% | 221,800 |
2019/01/11 | 3,300 | 3,330 | 3,215 | 3,225 | -50 | -1.5% | 114,600 |
2019/01/10 | 3,380 | 3,450 | 3,265 | 3,275 | -130 | -3.8% | 174,100 |
2019/01/09 | 3,435 | 3,465 | 3,340 | 3,405 | +5 | +0.1% | 200,700 |
2019/01/08 | 3,350 | 3,450 | 3,330 | 3,400 | +70 | +2.1% | 233,300 |
2019/01/07 | 3,355 | 3,375 | 3,250 | 3,330 | +115 | +3.6% | 239,400 |
2019/01/04 | 2,961 | 3,245 | 2,932 | 3,215 | +150 | +4.9% | 296,600 |
2018/12/28 | 3,055 | 3,155 | 3,025 | 3,065 | -55 | -1.8% | 206,400 |
2018/12/27 | 3,110 | 3,180 | 2,995 | 3,120 | +256 | +8.9% | 304,200 |
2018/12/26 | 2,934 | 2,970 | 2,768 | 2,864 | +96 | +3.5% | 288,300 |
2018/12/25 | 2,959 | 2,970 | 2,665 | 2,768 | -427 | -13.4% | 576,900 |
2018/12/21 | 3,240 | 3,295 | 3,100 | 3,195 | +25 | +0.8% | 265,200 |
2018/12/20 | 3,350 | 3,400 | 3,095 | 3,170 | -250 | -7.3% | 327,600 |
2018/12/19 | 3,445 | 3,525 | 3,265 | 3,420 | -15 | -0.4% | 200,400 |
2018/12/18 | 3,600 | 3,625 | 3,425 | 3,435 | -265 | -7.2% | 326,100 |
2018/12/17 | 3,825 | 3,880 | 3,685 | 3,700 | -165 | -4.3% | 137,600 |
2018/12/14 | 3,880 | 3,930 | 3,770 | 3,865 | +80 | +2.1% | 192,600 |
2018/12/13 | 3,800 | 3,865 | 3,735 | 3,785 | +15 | +0.4% | 145,800 |
2018/12/12 | 3,645 | 3,855 | 3,620 | 3,770 | -135 | -3.5% | 325,100 |
2018/12/11 | 3,940 | 3,995 | 3,855 | 3,905 | +20 | +0.5% | 148,900 |
2018/12/10 | 4,015 | 4,060 | 3,845 | 3,885 | -245 | -5.9% | 221,300 |
2018/12/07 | 4,140 | 4,190 | 4,040 | 4,130 | +80 | +2% | 193,000 |
2018/12/06 | 4,250 | 4,265 | 3,980 | 4,050 | -235 | -5.5% | 323,700 |
2018/12/05 | 4,145 | 4,340 | 4,130 | 4,285 | ±0 | ±0% | 201,800 |
2018/12/04 | 4,420 | 4,505 | 4,255 | 4,285 | -140 | -3.2% | 317,300 |
2018/12/03 | 4,365 | 4,425 | 4,265 | 4,425 | +200 | +4.7% | 267,000 |
2018/11/30 | 4,295 | 4,405 | 4,165 | 4,225 | -75 | -1.7% | 276,800 |
2018/11/29 | 4,335 | 4,375 | 4,255 | 4,300 | +50 | +1.2% | 251,900 |
2018/11/28 | 4,150 | 4,285 | 4,110 | 4,250 | +140 | +3.4% | 258,200 |
2018/11/27 | 4,075 | 4,190 | 4,025 | 4,110 | +80 | +2% | 248,600 |
2018/11/26 | 3,915 | 4,085 | 3,905 | 4,030 | +115 | +2.9% | 214,400 |
2018/11/22 | 3,870 | 3,955 | 3,820 | 3,915 | +45 | +1.2% | 176,400 |
2018/11/21 | 3,905 | 4,025 | 3,840 | 3,870 | -125 | -3.1% | 285,400 |
2018/11/20 | 3,960 | 4,050 | 3,875 | 3,995 | +25 | +0.6% | 339,700 |
2018/11/19 | 3,725 | 3,980 | 3,665 | 3,970 | +300 | +8.2% | 339,500 |
2018/11/16 | 3,670 | 3,780 | 3,660 | 3,670 | +35 | +1% | 207,200 |
2018/11/15 | 3,460 | 3,695 | 3,445 | 3,635 | +110 | +3.1% | 272,100 |
2018/11/14 | 3,700 | 3,825 | 3,475 | 3,525 | -40 | -1.1% | 380,900 |
2018/11/13 | 3,435 | 3,620 | 3,405 | 3,565 | -10 | -0.3% | 197,900 |
2018/11/12 | 3,665 | 3,755 | 3,545 | 3,575 | -125 | -3.4% | 209,200 |
2018/11/09 | 3,555 | 3,755 | 3,550 | 3,700 | +140 | +3.9% | 246,000 |
2018/11/08 | 3,570 | 3,630 | 3,520 | 3,560 | +95 | +2.7% | 167,100 |
2018/11/07 | 3,400 | 3,565 | 3,325 | 3,465 | +65 | +1.9% | 317,300 |
2018/11/06 | 3,460 | 3,490 | 3,330 | 3,400 | -30 | -0.9% | 159,600 |
2018/11/05 | 3,310 | 3,490 | 3,230 | 3,430 | +75 | +2.2% | 205,300 |
2018/11/02 | 3,290 | 3,375 | 3,265 | 3,355 | +155 | +4.8% | 189,100 |
1601~
1650
件表示中 / 3759件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ジーエヌアイ | 296,800円 | +21.7% | +999.9% | 0.00% | 12.44倍 | 4.12倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
科研薬 | 388,100円 | -6.4% | -71.8% | 4.90% | 43.35倍 | 0.97倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
東和薬品 | 294,600円 | +7.9% | -3.3% | 2.72% | 8.19倍 | 0.85倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
持田薬 | 322,500円 | +5.1% | -7.0% | 2.48% | 21.17倍 | 0.87倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ゼリア新薬 | 202,400円 | +3.1% | -6.5% | 2.37% | 9.39倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム